ReviewTherapeutics and clinical risk management2015
Optimal management of digital ulcers in systemic sclerosis.
Review in Therapeutics and clinical risk management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing and Comparing the Effect of Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers.
A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis
Who cites it
14 citing papers in PubMed, 38 citations in OpenAlex.
- Immersion Ultrasound Therapy in Combination with Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis.Medicina (Kaunas, Lithuania) · 2023Trial
- Article
- The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.Rheumatology and immunology research · 2022Article
- Rehabilitative interventions for ischaemic digital ulcers, pain, and hand functioning in systemic sclerosis: a prospective before-after study.BMC musculoskeletal disorders · 2022Article
- Study Protocol: A Randomized Controlled Prospective Single-Center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis (RHEACT Study).Frontiers in medicine · 2022Article
- Infections of scleroderma digital ulcers: A single center cohort retrospective study.Dermatology reports · 2021Article
- Microvascular Hand Surgery for Digital Ischemia in Scleroderma.Journal of scleroderma and related disorders · 2020Article
- Complementary therapies for patients with systemic sclerosis.Journal of scleroderma and related disorders · 2019Review
- Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.Clinical and experimental medicine · 2019Observational
- Serum level of endostatin and digital ulcers in systemic sclerosis patients.International wound journal · 2018Article
- Methacrylate dressing on refractory venous leg ulcers.BMJ case reports · 2018Article
- Review of local wound management for scleroderma-associated digital ulcers.Journal of scleroderma and related disorders · 2018Article
- Evidence-based management of Raynaud's phenomenon.Therapeutic advances in musculoskeletal disease · 2017Review
- The critical need for accurately defining digital ulcers in scleroderma.Journal of scleroderma and related disorders · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Raynaud's phenomenon and digital ulcerations are two common clinical features seen in patients with systemic sclerosis. They are painful and lead to significant morbidity and altered hand function within this patient population. While currently there are no US Food and Drug Administration (FDA)-approved medications for the treatment of digital ulcerations in the United States, clinical trials have supported the use of pharmacologic and nonpharmacologic modalities in facilitating healing of existing digital ulcers and preventing formation of new ulcers. This article reviews the published data on these therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.